Table 4.
Results of VAS scales in E, MT, and C groups of participants.
| Variable | Group | Before | After | p-Value3 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Median | Range | p-Value1 | Mean ± SD | Median | Range | p-Value2 | |||
| VAS left | E | 5.2 ± 2.7 a | 6.0 | 0–10.0 | 0.99 | 3.4 ± 2.1 a | 3.0 | 0–9.0 | 0.72 | <0.01 * |
| MT. | 5.2 ± 2.4 b | 6.0 | 0–8.0 | 3.2 ± 2.7 b | 3.0 | 0–8.0 | <0.01 * | |||
| VAS right | E | 5.0 ± 2.7 a | 5.0 | 0–10.0 | 0.89 | 3.4 ± 2.2 a | 3.0 | 0–9.0 | 0.56 | <0.01 * |
| MT. | 4.9 ± 2.7 b | 5.0 | 0–9.0 | 3.0 ± 2.6 | 2.0 | 0–8.0 | <0.01 | |||
p-value1—the comparison of intergroup VAS pre-treatment (Kruskal-Wallis test or Mann–Whitney U test); p-value2—the comparison of intergroup VAS post-treatment (Kruskal-Wallis test or Mann-Whitney U test); p-value3—the comparison of intragroup VAS pre- and post-treatment (dependent t-student test or * Wilcoxon signed ranked test); a,b—posthoc analysis.